Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations
- 24 March 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 23 (4), 654-662
- https://doi.org/10.1007/s11095-006-9663-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- IMPACT OF INCUBATION CONDITIONS ON BUFURALOL HUMAN CLEARANCE PREDICTIONS: ENZYME LABILITY AND NONSPECIFIC BINDINGDrug Metabolism and Disposition, 2004
- Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingJournal of Pharmaceutical Sciences, 2003
- Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl GlucuronideJournal of Pharmacology and Experimental Therapeutics, 2002
- Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential—towards a consensusBritish Journal of Clinical Pharmacology, 2001
- Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathwaysBiochemical Pharmacology, 1999
- Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3AJournal of Pharmacy and Pharmacology, 1998
- Bioavailability of Sublingual BuprenorphineThe Journal of Clinical Pharmacology, 1997
- Utility of in vitro drug metabolism data in predicting in vivo metabolic clearanceBiochemical Pharmacology, 1994
- Fluid Shifts and Other Factors Affecting Plasma Protein Binding of Prednisolone by Equilibrium DialysisJournal of Pharmaceutical Sciences, 1984
- Propranolol disposition in renal failure.British Journal of Clinical Pharmacology, 1980